Loading clinical trials...
Loading clinical trials...
A Study to Determine the Efficacy of Continuous Ambulatory Wearable Technology and a Cascading Alert System in Reducing 30d Readmission in High Risk Heart Failure Patients
Invasive telemonitoring has shown promising results in reducing readmissions and health service utilization, and improving patient outcomes; however, such evidence is lacking for non-invasive telemonitoring. Our proposal is to deploy a wearable solution that predicts physiological perturbation comparable to invasive devices and to perform continuous remote patient monitoring; this will be connected to a structured, cascading, escalation pathway involving home health nurses, advanced practitioner providers, specialists, and surgeons, and has the potential to transform care management in the post-discharge period, where patients are the most vulnerable for readmission.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
NorthShore University HealthSystem Evanston Hospital
Evanston, Illinois, United States
Start Date
December 14, 2020
Primary Completion Date
October 30, 2021
Completion Date
October 30, 2021
Last Updated
October 3, 2023
20
ACTUAL participants
Non-Invasive Continuous Remote Patient Monitoring
DEVICE
Affective Analysis of Participant Response to Continuous Remote Patient Monitoring
OTHER
Lead Sponsor
Endeavor Health
Collaborators
NCT07191730
NCT07484009
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions